Results 161 to 170 of about 4,792,921 (311)

Plasma Magnesium Concentration in Primary Hyperparathyroidism [PDF]

, 1970
R. A. L. Sutton
openalex   +1 more source

Use of Sodium‐Glucose Transport Protein 2 Inhibitors and the Incidence of Urolithiasis: A Multi‐Database and Cross‐Country Study in Patients With Type 2 Diabetes Mellitus

Clinical Pharmacology &Therapeutics, Volume 117, Issue 6, Page 1775-1783, June 2025.
The benefits of sodium‐glucose transport protein 2 inhibitor (SGLT2i) use on severe urolithiasis requiring surgery remains unclear. All patients with incident T2D in Taiwan National Health Institution databases (2016–2021) and TriNetX datasets (2014–2023) were retrospectively analyzed.
Mu‐Chi Chung, Chia‐Yen Lin, Chao‐Hsiang Chang, Yi‐Huei Chang, Po‐Jen Hsiao, Chi‐Shun Lien, Laing‐You Wu, Ming‐Ju Wu, Jeng‐Jer Shieh, Peir‐Haur Hung, Hsin‐Hua Chen, Chi‐Jung Chung   +11 more
wiley   +1 more source

Urinary cAMP Excretion during Surgery: An Index of Successful Parathyroidectomy in Patients with Primary Hyperparathyroidism* [PDF]

, 1978
Allen M. Spiegel, Stephen J. Marx, Murray F. Brennan, Edward M. Brown, Jan O. Koehler, G.D. Aurbach   +5 more
openalex   +1 more source

Primary hyperparathyroidism

The Lancet, 1997
A, al Zahrani, M A, Levine
openaire   +4 more sources

Fibroblast Growth Factor 23 and Sarcopenia in Maintenance Haemodialysis Population

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 3, June 2025.
ABSTRACT Background Sarcopenia is defined as the loss of muscle mass, strength, and/or performance. It is strongly associated with all‐cause mortality. Fibroblast growth factor 23 (FGF23) is markedly elevated in patients with chronic kidney disease, especially those receiving maintenance dialysis.
Limy Wong, Rachel Kenny, Jenny Y. Y. Ooi, Yung Shing Tsang, Emily Schembri, Lawrence P. McMahon   +5 more
wiley   +1 more source

Reliability of targeted surgical approach in the treatment of primary hyperparathyroidism [PDF]

Scripta Medica, 2017
Introduction: It is estimated that the prevalence of primary hyperparathyroidism in patients over 40 years is about 1 % (men 0.4 %, women 1.6 %). Despite developments in diagnosis today, the highest percentage of patients with hyperparathyroidism remains
Janičić Dušan, Grbić Slavko, Krupljanin Ljiljana, Krivokuća Božo, Kantar Marko   +4 more
doaj  

Global, regional and country‐specific burden of chronic kidney disease due to type 1 diabetes mellitus: A systematic analysis of the 2021 global disease burden study

Diabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 3397-3409, June 2025.
Abstract Aims Chronic kidney disease (CKD) affects individual welfare, healthcare systems and societal progress. Of the multifaceted etiological factors, type 1 diabetes mellitus (T1DM) is a prominent contributor to CKD. Materials and Methods We analysed the global incidence, prevalence, deaths and disability‐adjusted life‐years (DALYs) with age ...
Jianran Sun, Wan Hu, Shandong Ye, Min Xu, Datong Deng, Mingwei Chen   +5 more
wiley   +1 more source

Paget's disease and primary hyperparathyroidism. [PDF]

, 1978
E Lester
openalex   +1 more source

Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?

Clinics
Primary hyperparathyroidism is a common endocrinological disorder. In rare circumstances, it is associated with familial syndromes, such as multiple endocrine neoplasia type 1.
Francesca Giusti, Francesco Tonelli, Maria Luisa Brandi   +2 more
doaj   +1 more source

Primary hyperparathyroidism erosion of the sternal ends of the clavicles, a new sign of hyperparathy... [PDF]

, 1975
IW Chae, BC Rhee
openalex   +1 more source